Enell Smith, Karin http://orcid.org/0009-0004-2117-2503
Fritzell, Sara http://orcid.org/0000-0003-1079-2614
Nilsson, Anneli
Barchan, Karin
Rosén, Anna
Schultz, Lena
Varas, Laura
Säll, Anna
Rose, Nadia
Håkansson, Maria
von Schantz, Laura http://orcid.org/0000-0003-1236-3135
Ellmark, Peter http://orcid.org/0000-0002-6687-1250
Funding for this research was provided by:
Alligator Bioscience
Vinnova
Article History
Received: 6 August 2023
Accepted: 11 September 2023
First Online: 5 October 2023
Declarations
:
: All authors are employees of Alligator Bioscience AB and received compensation from and hold ownership interest in Alligator Bioscience, except for Nadia Rose and Maria Håkansson who are employed by Saromics Biostructures AB.
: All mice studies were conducted in accordance with the local guidelines by Biocytogen and ethical approval was provided by Institutional Animal Care and Use Committee (IACUC) of China (AUP No: 10278L001). Non-human primate studies were conducted at Charles River Laboratories Edinburgh UK, in accordance with and under the approval of the OECD Guideline 417, Committee for Medicinal Products for Human Use (CHMP) and ICH Harmonised Tripartite Guidelines M3 (R2), S3a, S7A, S7B and S9. Studies with human blood samples were conducted in accordance with international ethics guidelines, including the Declaration of Helsinki.
: This study does not involve human participants.
: Not applicable.